aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Corridor Pharmaceuticals is a biopharmaceutical company focused on developing therapeutic drugs for pulmonary, critical care, fibrosis, and vascular diseases. The company aims to serve patients and communities throughout the United States with innovative pharmaceutical products.
Corridor Pharmaceuticals has made significant strides in addressing critical care diseases, impacting patient care positively. The company is recognized for its commitment to advancing medical treatments and improving health outcomes in the US.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Pharmaceuticals, Drugs
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
United States
When was Corridor Pharmaceuticals founded?
Corridor Pharmaceuticals was founded in 2007.
Where is Corridor Pharmaceuticals’s headquarters located?
Corridor Pharmaceuticals’s headquarters is located in Towson, MD, US.
When was Corridor Pharmaceuticals’s last funding round?
Corridor Pharmaceuticals’s most recent funding round was for $1.6M (USD) in January 2013.
How many employees does Corridor Pharmaceuticals have?
Corridor Pharmaceuticals has 6 employees as of Feb 5, 2024.
How much has Corridor Pharmaceuticals raised to-date?
As of July 05, 2023, Corridor Pharmaceuticals has raised a total of $27.6M (USD) since Jan 31, 2013.
Add Comparison
Total Raised to Date
$27.6M
USD
Last Update Jan 31, 2013
Last Deal Details
$1.6M
USD
Jan 31, 2013
Debt Financing
Total Employees Over Time
6
As of Feb 2024
Corridor Pharmaceuticals Address
1122 Kenilworth Dr
suite 401
Towson,
Maryland
21204
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts